美邦股份: 陕西美邦药业集团股份有限公司第三届董事会第八次会议决议公告

Meeting Overview - The third board meeting of Shaanxi Meibang Pharmaceutical Group Co., Ltd. was held on August 25, 2025, in Xi'an, Shaanxi Province, with all 9 directors present [1] - The meeting was convened in accordance with the Company Law of the People's Republic of China and the company's articles of association [1] Resolutions Passed - The board approved the 2025 semi-annual report and summary, which had previously been reviewed by the audit committee [2] - The board approved the special report on the storage and actual use of raised funds for the first half of 2025, also reviewed by the audit committee [2] - The board agreed to cancel the supervisory board and amend the articles of association, which will require shareholder approval [2][3] - The board passed resolutions to revise and abolish certain management systems, all requiring shareholder approval [3][4] - The board approved the convening of the first extraordinary general meeting of 2025 to be held on September 26, 2025 [5]